---
title: "Fujian Cosunter Pharmaceutical Co.,Ltd. (300436.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300436.SZ.md"
symbol: "300436.SZ"
name: "Fujian Cosunter Pharmaceutical Co.,Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-20T01:32:43.938Z"
locales:
  - [en](https://longbridge.com/en/quote/300436.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300436.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300436.SZ.md)
---

# Fujian Cosunter Pharmaceutical Co.,Ltd. (300436.SZ)

## Company Overview

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.cosunter.com](https://www.cosunter.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: D (0.71)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 179 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.43% |  |
| Net Profit YoY | -26.53% |  |
| P/B Ratio | 77.44 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 19464527406.14 |  |
| Revenue | 416807074.91 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -73.82% | E |
| Profit Margin | -51.60% | E |
| Gross Margin | 66.95% | A |
| Revenue YoY | -0.43% | D |
| Net Profit YoY | -26.53% | D |
| Total Assets YoY | 2.24% | C |
| Net Assets YoY | -13.91% | E |
| Cash Flow Margin | 19.78% | D |
| OCF YoY | -0.43% | D |
| Turnover | 0.30 | D |
| Gearing Ratio | 77.64% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Fujian Cosunter Pharmaceutical Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-0.43%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-26.53%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "77.44",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "19464527406.14",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "416807074.91",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-73.82%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-51.60%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "66.95%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-0.43%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-26.53%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.24%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-13.91%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "19.78%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-0.43%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.30",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "77.64%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -93.31 | 211/215 | - | - | - |
| PB | 79.84 | 220/215 | 60.89 | 44.86 | 35.88 |
| PS (TTM) | 48.15 | 219/215 | 44.59 | 38.54 | 31.04 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300436.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300436.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300436.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300436.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**